Your email has been successfully added to our mailing list.

×
0.0480769230769231 0.0480769230769231 0.00480769230769242 -0.0384615384615385 -0.0432692307692308 -0.0817307692307692 -0.0636538461538462 -0.0871153846153846
Stock impact report

Akari Therapeutics Announces Positive Phase II Clinical Data in Orphan Blistering Skin Disease Bullous Pemphigoid at the 28th EADV Congress

Akari Therapeutics Plc - American Depositary Shares (AKTX) 
US:NASDAQ Investor Relations: investor.akaritx.com/investor-relations
Company Research Source: GlobeNewswire
Treatment with nomacopan in six patients in Phase II trial was well tolerated and resulted in rapid onset of clinical improvement in five of six patients– No reported drug-related serious adverse events– Achieved marked reduction in Bullous Pemphigoid Disease Area Index (BPDAI) activity score and blistering Potential as monotherapy with the additional potential benefit of reducing steroid use which has multiple adverse effects in this frail population° Two patients who received nomacopan monotherapy performed as well as those on a combined initial low-dose topical steroid plus nomacopanAkari intends to present this new Phase II data to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to advance its potential pivotal trial design for patients with BPNomacopan recently granted orphan drug designation by the FDA for the treatment of BP NEW YORK and LONDON, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharm Show less Read more
Impact Snapshot
Event Time:
AKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
AKTX alerts

from News Quantified
Opt-in for
AKTX alerts

from News Quantified